MEDNAX, Inc. (NYSE:MD) acquired Tri-Valley Neonatal Medical Group, Inc. on January 10, 2018. Consideration is paid in cash. Sukshma Sreepathi will serve as medical director of Tri-Valley Neonatal Medical Group, Inc. The acquisition is expected to be immediately accretive to earnings. MEDNAX, Inc. (NYSE:MD) completed the acquisition of Tri-Valley Neonatal Medical Group, Inc. on January 10, 2018.